Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vertex Pharmaceutic (VRTX)

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,182,208
  • Shares Outstanding, K 258,866
  • Annual Sales, $ 6,206 M
  • Annual Income, $ 2,712 M
  • 60-Month Beta 0.66
  • Price/Sales 8.36
  • Price/Cash Flow 20.93
  • Price/Book 5.78
Trade VRTX with:

Options Overview

Details
  • Implied Volatility 24.88%
  • Historical Volatility 16.21%
  • IV Percentile 2%
  • IV Rank 5.12%
  • IV High 51.43% on 05/27/21
  • IV Low 23.45% on 06/23/21
  • Put/Call Vol Ratio 0.40
  • Today's Volume 1,852
  • Volume Avg (30-Day) 1,843
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 62,410
  • Open Int (30-Day) 80,877

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 2.29
  • Number of Estimates 6
  • High Estimate 2.64
  • Low Estimate 1.27
  • Prior Year 2.36
  • Growth Rate Est. (year over year) -2.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
193.88 +2.29%
on 07/20/21
204.88 -3.20%
on 07/28/21
-2.22 (-1.11%)
since 07/02/21
3-Month
185.32 +7.01%
on 06/22/21
219.69 -9.73%
on 05/03/21
-19.88 (-9.11%)
since 04/30/21
52-Week
185.32 +7.01%
on 06/22/21
283.45 -30.03%
on 09/02/20
-73.68 (-27.09%)
since 07/31/20

Most Recent Stories

More News
Huntington’s Disease Therapeutics Market Size, Share, Trends, Analysis and Forecast 2027

The report on Huntington’s Disease Therapeutics provides the clients with a comprehensive analysis of crucial driving factors, consumer behavior, growth trends, product utilization, key player analysis,...

APHB : 0.32 (-20.33%)
CORX : 1.0000 (-0.99%)
GSK : 40.24 (+0.25%)
PRAN : 2.06 (unch)
RPTP : 9.00 (unch)
VRX.TO : 30.80 (-3.33%)
VRTX : 198.32 (-1.62%)
Vertex (VRTX) Q2 Earnings Beat Estimates, 2021 Guidance Up

Vertex's (VRTX) earnings and sales beat estimates in the second quarter of 2021. The company raises revenue guidance for the year.

VRTX : 198.32 (-1.62%)
RGEN : 247.87 (+0.88%)
TECH : 485.74 (+0.73%)
CRSP : 122.34 (+1.09%)
CRISPR Therapeutics (CRSP) Q2 Earnings Beat, Revenues Up Y/Y

CRISPR Therapeutics' (CRSP) earnings and revenues beat estimates in the second quarter of 2021. Pipeline development in focus.

VRTX : 198.32 (-1.62%)
RGEN : 247.87 (+0.88%)
TECH : 485.74 (+0.73%)
CRSP : 122.34 (+1.09%)
Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Surpass Estimates

Vertex (VRTX) delivered earnings and revenue surprises of 15.61% and 4.93%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

VRTX : 198.32 (-1.62%)
Vertex: Q2 Earnings Snapshot

BOSTON (AP) _ Vertex Pharmaceuticals Inc. (VRTX) on Thursday reported second-quarter earnings of $66.9 million.

VRTX : 198.32 (-1.62%)
Vertex Reports Second-Quarter 2021 Financial Results

--- Company raises full-year 2021 guidance for product revenues to $7.2 to $7.4B -

VRTX : 198.32 (-1.62%)
Ironwood (IRWD) Hits 52-Week High, Can the Run Continue?

Ironwood (IRWD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

IRWD : 13.27 (unch)
VRTX : 198.32 (-1.62%)
REPH : 1.8600 (+2.20%)
SPRCY : 5.1300 (-1.91%)
Vertex to Initiate Phase 3 Development Program for New Once-Daily Triple Combination Regimen in People With Cystic Fibrosis

--- Phase 2 data demonstrated that a once-daily triple combination of VX-121/ tezacaftor/VX-561 has potential for enhanced clinical benefit compared to TRIKAFTA(R) (elexacaftor/tezacaftor/ivacaftor and...

VRTX : 198.32 (-1.62%)
Vertex (VRTX) to Report Q2 Earnings: What's in the Cards?

On Vertex's (VRTX) second-quarter earnings call, investor focus is likely to be on the sales performance of its triple combo CF drug Trikafta and pipeline progress.

VRTX : 198.32 (-1.62%)
ILMN : 492.99 (-0.56%)
SRPT : 68.59 (+1.20%)
APTO : 2.66 (-1.12%)
CRISPR (CRSP) to Report Q2 Earnings: What's in the Cards?

On CRISPR Therapeutics' (CRSP) Q2 earnings call, investors will look forward to the company's advancement with its lead gene-editing candidate CTX001.

VRTX : 198.32 (-1.62%)
ILMN : 492.99 (-0.56%)
CRSP : 122.34 (+1.09%)
APTO : 2.66 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs...

See More

Key Turning Points

3rd Resistance Point 204.40
2nd Resistance Point 202.83
1st Resistance Point 200.58
Last Price 198.32
1st Support Level 196.76
2nd Support Level 195.19
3rd Support Level 192.94

See More

52-Week High 283.45
Fibonacci 61.8% 245.97
Fibonacci 50% 234.39
Fibonacci 38.2% 222.81
Last Price 198.32
52-Week Low 185.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar